Actively Recruiting
Using Dichoptic Therapy to Treat Intermittent Exotropia
Led by Virginia Commonwealth University · Updated on 2025-10-08
20
Participants Needed
1
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Intermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomized control trial and was not found to have a large benefit. More non-surgical treatment modalities are critical to improve the care in this condition.
CONDITIONS
Official Title
Using Dichoptic Therapy to Treat Intermittent Exotropia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with intermittent exotropia (IXT)
- Has one preferred eye
- Aged between 4 and 7 years
- Distance control scores of 4 or less
You will not qualify if you...
- Distance control scores of 5
- Visual acuity worse in one eye by more than two lines
- No preferred eye
- Unable to tolerate wearing the headset for 1 hour per day, 6 days a week, for 12 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
Actively Recruiting
Research Team
E
Evan Silverstein
CONTACT
E
Emilia Varrone
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here